671 related articles for article (PubMed ID: 28379073)
21. Neuromyelitis Optica Spectrum Disorders.
Akaishi T; Nakashima I; Sato DK; Takahashi T; Fujihara K
Neuroimaging Clin N Am; 2017 May; 27(2):251-265. PubMed ID: 28391784
[TBL] [Abstract][Full Text] [Related]
22. Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome.
Chen JJ; Flanagan EP; Jitprapaikulsan J; López-Chiriboga ASS; Fryer JP; Leavitt JA; Weinshenker BG; McKeon A; Tillema JM; Lennon VA; Tobin WO; Keegan BM; Lucchinetti CF; Kantarci OH; McClelland CM; Lee MS; Bennett JL; Pelak VS; Chen Y; VanStavern G; Adesina OO; Eggenberger ER; Acierno MD; Wingerchuk DM; Brazis PW; Sagen J; Pittock SJ
Am J Ophthalmol; 2018 Nov; 195():8-15. PubMed ID: 30055153
[TBL] [Abstract][Full Text] [Related]
23. Myelin oligodendrocyte glycoprotein antibodies in neuromyelitis optica spectrum disorder.
de Seze J
Curr Opin Neurol; 2019 Feb; 32(1):111-114. PubMed ID: 30562266
[TBL] [Abstract][Full Text] [Related]
24. [Optic neuropathy in positive anti-MOG antibody syndrome].
Merabtene L; Vignal Clermont C; Deschamps R
J Fr Ophtalmol; 2019 Dec; 42(10):1100-1110. PubMed ID: 31732265
[TBL] [Abstract][Full Text] [Related]
25. Clinical characteristics and prognosis of myelin oligodendrocyte glycoprotein antibody-seropositive paediatric optic neuritis in China.
Song H; Zhou H; Yang M; Tan S; Wang J; Xu Q; Liu H; Wei S
Br J Ophthalmol; 2019 Jun; 103(6):831-836. PubMed ID: 30049802
[TBL] [Abstract][Full Text] [Related]
26. Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis.
Nakajima H; Motomura M; Tanaka K; Fujikawa A; Nakata R; Maeda Y; Shima T; Mukaino A; Yoshimura S; Miyazaki T; Shiraishi H; Kawakami A; Tsujino A
BMJ Open; 2015 Apr; 5(4):e007766. PubMed ID: 25838512
[TBL] [Abstract][Full Text] [Related]
27. Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies.
Lee HJ; Kim B; Waters P; Woodhall M; Irani S; Ahn S; Kim SJ; Kim SM
J Neuroinflammation; 2018 Oct; 15(1):302. PubMed ID: 30382857
[TBL] [Abstract][Full Text] [Related]
28. Clinical profile, imaging features and short term visual outcomes of Indian optic neuritis patients with and without seromarkers for myelin oligodendrocyte glycoprotein and neuromyelitis optica.
Ambika S; Durgapriyadarshini S; Padmalakshmi K; Noronha V; Arjundas D
Indian J Ophthalmol; 2022 Jan; 70(1):194-200. PubMed ID: 34937238
[TBL] [Abstract][Full Text] [Related]
29. Myelin Oligodendrocyte Glycoprotein-Associated Pediatric Central Nervous System Demyelination: Clinical Course, Neuroimaging Findings, and Response to Therapy.
Thulasirajah S; Pohl D; Davila-Acosta J; Venkateswaran S
Neuropediatrics; 2016 Aug; 47(4):245-52. PubMed ID: 27128728
[TBL] [Abstract][Full Text] [Related]
30. Detection of Autoantibodies Against Myelin Oligodendrocyte Glycoprotein in Multiple Sclerosis and Related Diseases.
Spadaro M; Meinl E
Methods Mol Biol; 2016; 1304():99-104. PubMed ID: 25814289
[TBL] [Abstract][Full Text] [Related]
31. Myelin oligodendrocyte glycoprotein antibody associated central nervous system demyelinating disease: a tertiary center experience from Turkey.
Inan B; Gocmen R; Vural A; Colpak AI; Meinl E; Karabudak R; Tuncer A
Mult Scler Relat Disord; 2020 Sep; 44():102376. PubMed ID: 32674059
[TBL] [Abstract][Full Text] [Related]
32. Seronegative Neuromyelitis Optica Spectrum--the challenges on disease definition and pathogenesis.
Sato DK; Callegaro D; Lana-Peixoto MA; Nakashima I; Fujihara K
Arq Neuropsiquiatr; 2014 Jun; 72(6):445-50. PubMed ID: 24964112
[TBL] [Abstract][Full Text] [Related]
33. Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination.
Ramanathan S; Mohammad S; Tantsis E; Nguyen TK; Merheb V; Fung VSC; White OB; Broadley S; Lechner-Scott J; Vucic S; Henderson APD; Barnett MH; Reddel SW; Brilot F; Dale RC;
J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):127-137. PubMed ID: 29142145
[TBL] [Abstract][Full Text] [Related]
34. [Anti-Myelin Oligodendrocyte Glycoprotein Antibody Associated Disease].
Fujimori J; Nakashima I
Brain Nerve; 2021 May; 73(5):483-488. PubMed ID: 34006679
[TBL] [Abstract][Full Text] [Related]
35. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
[TBL] [Abstract][Full Text] [Related]
36. MRI pattern in acute optic neuritis: Comparing multiple sclerosis, NMO and MOGAD.
Darakdjian M; Chaves H; Hernandez J; Cejas C
Neuroradiol J; 2023 Jun; 36(3):267-272. PubMed ID: 36062458
[TBL] [Abstract][Full Text] [Related]
37. Anti-MOG antibodies in adult patients with demyelinating disorders of the central nervous system.
Tanaka M; Tanaka K
J Neuroimmunol; 2014 May; 270(1-2):98-9. PubMed ID: 24703097
[TBL] [Abstract][Full Text] [Related]
38. Comparing myelin oligodendrocyte glycoprotein antibody (MOG-Ab) and non MOG-Ab associated optic neuritis: Clinical course and treatment outcome.
Etemadifar M; Abbasi M; Salari M; Etemadifar F; Tavakoli H
Mult Scler Relat Disord; 2019 Jan; 27():127-130. PubMed ID: 30368225
[TBL] [Abstract][Full Text] [Related]
39. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica.
Rostásy K; Mader S; Hennes EM; Schanda K; Gredler V; Guenther A; Blaschek A; Korenke C; Pritsch M; Pohl D; Maier O; Kuchukhidze G; Brunner-Krainz M; Berger T; Reindl M
Mult Scler; 2013 Jul; 19(8):1052-9. PubMed ID: 23257621
[TBL] [Abstract][Full Text] [Related]
40. Acute idiopathic optic neuritis: not always benign.
Deschamps R; Gueguen A; Lecler A; Lecouturier K; Lamirel C; Bensa C; Marignier R; Vignal C; Gout O
Eur J Neurol; 2018 Nov; 25(11):1378-1383. PubMed ID: 30004610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
